Key Binding Characteristics of Dusquetide to Important Intracellular Protein Identified
Fox 8 WVUE,
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Paper published in the Journal Structure PRINCETON, N.J., June 1, 2022 /PRNewswire/ -- Soligenix, Inc.
Complementary treatment with chemotherapy, radiation and targeted therapy supports development as potential anti-cancer agent…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
Complementary treatment with chemotherapy, radiation and targeted therapy supports development as potential anti-cancer agent…
Complementary treatment with chemotherapy, radiation and targeted therapy supports development as potential anti-cancer agent…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
Complementary treatment with chemotherapy, radiation and targeted therapy supports development as potential anti-cancer agent…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
Complementary treatment with chemotherapy, radiation and targeted therapy supports development as potential anti-cancer agent…
Dusquetide Demonstrates Positive Anti-tumor Efficacy in Multiple Nonclinical Animal Studies Complementary treatment with…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
Complementary treatment with chemotherapy, radiation and targeted therapy supports development as potential anti-cancer agent…
Complementary treatment with chemotherapy, radiation and targeted therapy supports development as potential anti-cancer agent…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
Complementary treatment with chemotherapy, radiation and targeted therapy supports development as potential anti-cancer agent…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
Complementary treatment with chemotherapy, radiation and targeted therapy supports development as potential anti-cancer agent…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
Complementary treatment with chemotherapy, radiation and targeted therapy supports development as potential anti-cancer agent…
Complementary treatment with chemotherapy, radiation and targeted therapy supports development as potential anti-cancer agent…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
PRINCETON, N.J., Jan. 4, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
? uncertainty inherent in developing therapeutics and vaccines, and manufacturing and conducting preclinical and clinical trials…
PR Newswire PRINCETON, N.J., July 20, 2020 PRINCETON, N.J., July 20, 2020 /PRNewswire/ -- Soligenix, Inc.
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
PRINCETON, N.J., July 20, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: ) (Soligenix or the Company), a late-stage…
This clinical trial success was a tremendous accomplishment for the company, and we are eagerly anticipating other important…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
PRINCETON, N.J., July 20, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX ) (Soligenix or the Company), a late-stage…
Boston Scientific-Aktie dauerhaft für 0 Euro handeln! Jetzt auf Smartbroker.de PR Newswire PRINCETON, N.J., July 20, 2020…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
/PRNewswire/ --. (Nasdaq: SNGX ) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and…
/PRNewswire/ --. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and…
Soligenix Issues Corporate Update - Highlights Important Catalysts for Second Half of 2020 PR Newswire PRINCETON, N.J., July 20…
/PRNewswire/ --. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and…
SOURCE Soligenix, Inc. Final topline results remain on target for first half 2020 PRINCETON, N.J.
SOURCE Soligenix, Inc. Final topline results remain on target for first half 2020 PRINCETON, N.J.
SOURCE Soligenix, Inc. Exploring Dusquetide in Broader Populations PRINCETON, N.J.
SOURCE Soligenix, Inc. Exploring Dusquetide in Broader Populations PRINCETON, N.J.
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and…
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and…
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and…
Exploring Dusquetide in Broader Populations PRINCETON, N.J., Aug. 15, 2019 /PRNewswire/ -- Soligenix, Inc.
PRINCETON, N.J., Aug. 15, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage…
Exploring Dusquetide in Broader Populations PRINCETON, N.J., Aug. 15, 2019 /PRNewswire/ -- Soligenix, Inc.
Exploring Dusquetide in Broader Populations PRINCETON, N.J., Aug. 15, 2019 /PRNewswire/ -- Soligenix, Inc.
SOURCE Soligenix, Inc. Enrollment Sufficient to Support the Interim Efficacy Analysis PRINCETON, N.J.
SOURCE Soligenix, Inc. Enrollment Sufficient to Support the Interim Efficacy Analysis PRINCETON, N.J.
SOURCE Soligenix, Inc. Enrollment Sufficient to Support the Interim Efficacy Analysis PRINCETON, N.J.
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
Enrollment Sufficient to Support the Interim Efficacy Analysis PRINCETON, N.J., April 18, 2019 /PRNewswire/ -- Soligenix, Inc.
Acceptance of Pediatric Investigation Plan is important milestone on the path to submission of Marketing Authorization…
SOURCE Soligenix, Inc. Acceptance of Pediatric Investigation Plan is important milestone on the path to submission of Marketing…
SOURCE Soligenix, Inc. Acceptance of Pediatric Investigation Plan is important milestone on the path to submission of Marketing…
SOURCE Soligenix, Inc. Acceptance of Pediatric Investigation Plan is important milestone on the path to submission of Marketing…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
Acceptance of Pediatric Investigation Plan is important milestone on the path to submission of Marketing Authorization…
Acceptance of Pediatric Investigation Plan is important milestone on the path to submission of Marketing Authorization…
Patent broadens protection in infectious disease and oral mucositis, including composition of matter claims PRINCETON, N.J.
SOURCE Soligenix, Inc. Patent broadens protection in infectious disease and oral mucositis, including composition of matter…
SOURCE Soligenix, Inc. Patent broadens protection in infectious disease and oral mucositis, including composition of matter…
SOURCE Soligenix, Inc. Patent broadens protection in infectious disease and oral mucositis, including composition of matter…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
Patent broadens protection in infectious disease and oral mucositis, including composition of matter claims PRINCETON, N.J.…
Patent broadens protection in infectious disease and oral mucositis, including composition of matter claims PRINCETON, N.J.…
SOURCE Soligenix, Inc. PRINCETON, N.J. Soligenix applied for the CAP as part of its $1.5 million "We are appreciative of the…
SOURCE Soligenix, Inc. PRINCETON, N.J. Soligenix applied for the CAP as part of its $1.5 million "We are appreciative of the…
SOURCE Soligenix, Inc. PRINCETON, N.J. Soligenix applied for the CAP as part of its $1.5 million "We are appreciative of the…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
SOURCE Soligenix, Inc. PRINCETON, N.J. Soligenix applied for the CAP as part of its $1.5 million "We are appreciative of the…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and…
/ / -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing…
/PRNewswire/ --. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and…
/PRNewswire/ -- Soligenix, Inc. (Nasdaq:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on…